The regulation of pharmaceuticals: balancing the benefits and risks
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Washington [u.a.]
American Enterprise Inst. for Public Policy Research
1983
|
Schriftenreihe: | AEI studies
377 |
Schlagworte: | |
Beschreibung: | 74 S. graph. Darst. |
ISBN: | 0844735175 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV006139860 | ||
003 | DE-604 | ||
005 | 20130716 | ||
007 | t | ||
008 | 921030s1983 d||| |||| 00||| eng d | ||
020 | |a 0844735175 |9 0-8447-3517-5 | ||
035 | |a (OCoLC)9219340 | ||
035 | |a (DE-599)BVBBV006139860 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-703 |a DE-739 |a DE-188 |a DE-706 | ||
050 | 0 | |a KF3885.G7 1983 | |
082 | 0 | |a 347.3044233 |2 19 | |
082 | 0 | |a 344.7304233 | |
082 | 0 | |a 344.73/04233 |2 19 | |
084 | |a PJ 3900 |0 (DE-625)136838: |2 rvk | ||
084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
100 | 1 | |a Grabowski, Henry G. |e Verfasser |4 aut | |
245 | 1 | 0 | |a The regulation of pharmaceuticals |b balancing the benefits and risks |c Henry G. Grabowski ; John M. Vernon |
264 | 1 | |a Washington [u.a.] |b American Enterprise Inst. for Public Policy Research |c 1983 | |
300 | |a 74 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a AEI studies |v 377 | |
490 | 0 | |a American Enterprise Institute Studies in government regulation | |
490 | 0 | |a Evaluative studies of health, safety, and environmental programs | |
610 | 1 | 4 | |a États-Unis - Food and Drug Administration |
610 | 2 | 4 | |a United States |b Food and Drug Administration |
650 | 4 | |a Médicaments - Droit - États-Unis | |
650 | 4 | |a Pharmacie - Droit - États-Unis | |
650 | 4 | |a Recht | |
650 | 4 | |a Drugs |x Law and legislation |z United States | |
650 | 4 | |a Pharmacy |x Law and legislation |z United States | |
650 | 4 | |a Drug industry |x Standards |z United States | |
650 | 4 | |a Drugs |x Standards | |
650 | 4 | |a Legislation, Drug |z United States | |
650 | 4 | |a Research |x Standards |z United States | |
650 | 0 | 7 | |a Überwachung |0 (DE-588)4134175-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Staatsaufsicht |0 (DE-588)4056636-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
651 | 4 | |a USA | |
651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 0 | 2 | |a Überwachung |0 (DE-588)4134175-2 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 1 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 1 | 2 | |a Staatsaufsicht |0 (DE-588)4056636-5 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Vernon, John M. |d 1937- |e Verfasser |0 (DE-588)132332760 |4 aut | |
830 | 0 | |a AEI studies |v 377 |w (DE-604)BV000001481 |9 377 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-003880767 |
Datensatz im Suchindex
_version_ | 1804120365247496192 |
---|---|
any_adam_object | |
author | Grabowski, Henry G. Vernon, John M. 1937- |
author_GND | (DE-588)132332760 |
author_facet | Grabowski, Henry G. Vernon, John M. 1937- |
author_role | aut aut |
author_sort | Grabowski, Henry G. |
author_variant | h g g hg hgg j m v jm jmv |
building | Verbundindex |
bvnumber | BV006139860 |
callnumber-first | K - Law |
callnumber-label | KF3885 |
callnumber-raw | KF3885.G7 1983 |
callnumber-search | KF3885.G7 1983 |
callnumber-sort | KF 43885 G7 41983 |
callnumber-subject | KF - United States |
classification_rvk | PJ 3900 QR 525 |
ctrlnum | (OCoLC)9219340 (DE-599)BVBBV006139860 |
dewey-full | 347.3044233 344.7304233 344.73/04233 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 347 - Procedure and courts 344 - Labor, social, education & cultural law |
dewey-raw | 347.3044233 344.7304233 344.73/04233 |
dewey-search | 347.3044233 344.7304233 344.73/04233 |
dewey-sort | 3347.3044233 |
dewey-tens | 340 - Law |
discipline | Rechtswissenschaft Wirtschaftswissenschaften |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02522nam a2200673 cb4500</leader><controlfield tag="001">BV006139860</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130716 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921030s1983 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0844735175</subfield><subfield code="9">0-8447-3517-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)9219340</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006139860</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-706</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">KF3885.G7 1983</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">347.3044233</subfield><subfield code="2">19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">344.7304233</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">344.73/04233</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PJ 3900</subfield><subfield code="0">(DE-625)136838:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Grabowski, Henry G.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The regulation of pharmaceuticals</subfield><subfield code="b">balancing the benefits and risks</subfield><subfield code="c">Henry G. Grabowski ; John M. Vernon</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington [u.a.]</subfield><subfield code="b">American Enterprise Inst. for Public Policy Research</subfield><subfield code="c">1983</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">74 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">AEI studies</subfield><subfield code="v">377</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">American Enterprise Institute Studies in government regulation</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Evaluative studies of health, safety, and environmental programs</subfield></datafield><datafield tag="610" ind1="1" ind2="4"><subfield code="a">États-Unis - Food and Drug Administration</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">United States</subfield><subfield code="b">Food and Drug Administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Droit - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacie - Droit - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug industry</subfield><subfield code="x">Standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield><subfield code="x">Standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Überwachung</subfield><subfield code="0">(DE-588)4134175-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Staatsaufsicht</subfield><subfield code="0">(DE-588)4056636-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Überwachung</subfield><subfield code="0">(DE-588)4134175-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Staatsaufsicht</subfield><subfield code="0">(DE-588)4056636-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vernon, John M.</subfield><subfield code="d">1937-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)132332760</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">AEI studies</subfield><subfield code="v">377</subfield><subfield code="w">(DE-604)BV000001481</subfield><subfield code="9">377</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003880767</subfield></datafield></record></collection> |
geographic | USA USA (DE-588)4078704-7 gnd |
geographic_facet | USA |
id | DE-604.BV006139860 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:40:56Z |
institution | BVB |
isbn | 0844735175 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003880767 |
oclc_num | 9219340 |
open_access_boolean | |
owner | DE-703 DE-739 DE-188 DE-706 |
owner_facet | DE-703 DE-739 DE-188 DE-706 |
physical | 74 S. graph. Darst. |
publishDate | 1983 |
publishDateSearch | 1983 |
publishDateSort | 1983 |
publisher | American Enterprise Inst. for Public Policy Research |
record_format | marc |
series | AEI studies |
series2 | AEI studies American Enterprise Institute Studies in government regulation Evaluative studies of health, safety, and environmental programs |
spelling | Grabowski, Henry G. Verfasser aut The regulation of pharmaceuticals balancing the benefits and risks Henry G. Grabowski ; John M. Vernon Washington [u.a.] American Enterprise Inst. for Public Policy Research 1983 74 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier AEI studies 377 American Enterprise Institute Studies in government regulation Evaluative studies of health, safety, and environmental programs États-Unis - Food and Drug Administration United States Food and Drug Administration Médicaments - Droit - États-Unis Pharmacie - Droit - États-Unis Recht Drugs Law and legislation United States Pharmacy Law and legislation United States Drug industry Standards United States Drugs Standards Legislation, Drug United States Research Standards United States Überwachung (DE-588)4134175-2 gnd rswk-swf Staatsaufsicht (DE-588)4056636-5 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Arzneimittel (DE-588)4003115-9 s Überwachung (DE-588)4134175-2 s DE-604 Staatsaufsicht (DE-588)4056636-5 s Vernon, John M. 1937- Verfasser (DE-588)132332760 aut AEI studies 377 (DE-604)BV000001481 377 |
spellingShingle | Grabowski, Henry G. Vernon, John M. 1937- The regulation of pharmaceuticals balancing the benefits and risks AEI studies États-Unis - Food and Drug Administration United States Food and Drug Administration Médicaments - Droit - États-Unis Pharmacie - Droit - États-Unis Recht Drugs Law and legislation United States Pharmacy Law and legislation United States Drug industry Standards United States Drugs Standards Legislation, Drug United States Research Standards United States Überwachung (DE-588)4134175-2 gnd Staatsaufsicht (DE-588)4056636-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
subject_GND | (DE-588)4134175-2 (DE-588)4056636-5 (DE-588)4003115-9 (DE-588)4078704-7 |
title | The regulation of pharmaceuticals balancing the benefits and risks |
title_auth | The regulation of pharmaceuticals balancing the benefits and risks |
title_exact_search | The regulation of pharmaceuticals balancing the benefits and risks |
title_full | The regulation of pharmaceuticals balancing the benefits and risks Henry G. Grabowski ; John M. Vernon |
title_fullStr | The regulation of pharmaceuticals balancing the benefits and risks Henry G. Grabowski ; John M. Vernon |
title_full_unstemmed | The regulation of pharmaceuticals balancing the benefits and risks Henry G. Grabowski ; John M. Vernon |
title_short | The regulation of pharmaceuticals |
title_sort | the regulation of pharmaceuticals balancing the benefits and risks |
title_sub | balancing the benefits and risks |
topic | États-Unis - Food and Drug Administration United States Food and Drug Administration Médicaments - Droit - États-Unis Pharmacie - Droit - États-Unis Recht Drugs Law and legislation United States Pharmacy Law and legislation United States Drug industry Standards United States Drugs Standards Legislation, Drug United States Research Standards United States Überwachung (DE-588)4134175-2 gnd Staatsaufsicht (DE-588)4056636-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
topic_facet | États-Unis - Food and Drug Administration United States Food and Drug Administration Médicaments - Droit - États-Unis Pharmacie - Droit - États-Unis Recht Drugs Law and legislation United States Pharmacy Law and legislation United States Drug industry Standards United States Drugs Standards Legislation, Drug United States Research Standards United States Überwachung Staatsaufsicht Arzneimittel USA |
volume_link | (DE-604)BV000001481 |
work_keys_str_mv | AT grabowskihenryg theregulationofpharmaceuticalsbalancingthebenefitsandrisks AT vernonjohnm theregulationofpharmaceuticalsbalancingthebenefitsandrisks |